Correlation Between Vivos Therapeutics and Artivion

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Artivion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Artivion into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Artivion, you can compare the effects of market volatilities on Vivos Therapeutics and Artivion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Artivion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Artivion.

Diversification Opportunities for Vivos Therapeutics and Artivion

0.65

Correlation Coefficient

Vivos Therapeutics  Artivion

Poor diversification

The 3 months correlation between Vivos and Artivion is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Artivion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artivion and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Artivion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artivion has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Artivion go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Artivion

Given the investment horizon of 90 days Vivos Therapeutics is expected to under-perform the Artivion. In addition to that, Vivos Therapeutics is 3.04 times more volatile than Artivion. It trades about -0.06 of its total potential returns per unit of risk. Artivion is currently generating about -0.12 per unit of volatility. If you would invest  2,859  in Artivion on December 29, 2024 and sell it today you would lose (409.00) from holding Artivion or give up 14.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Vivos Therapeutics  vs.  Artivion

Vivos Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vivos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Artivion

Risk-Adjusted Performance

Very Weak

Over the last 90 days Artivion has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Vivos Therapeutics and Artivion

The main advantage of trading using opposite Vivos Therapeutics and Artivion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Artivion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artivion will offset losses from the drop in Artivion's long position.

The idea behind Vivos Therapeutics and Artivion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.